Why is Hemo Organic falling/rising?

As of 17-Jul, Hemo Organic Ltd's stock price is currently at 9.53, reflecting a decrease of 0.5, or 4.99%. The stock has underperformed its sector by 4.76% today and has shown erratic trading patterns, not trading on one day out of the last 20. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -11.92%, and it has consistently underperformed against the benchmark, with a significant decline of 73.71% over the last three years. Despite some positive quarterly results, including the highest PBDIT and PAT figures, the company faces challenges such as a negative book value, high debt levels, and a weak long-term growth outlook, which contribute to its current price decline.
In the broader market context, Hemo Organic's short-term performance of -0.10% over the past week contrasts with the Sensex's decline of 1.12%, indicating a relatively better performance in that timeframe. However, the stock's year-to-date performance is significantly worse than the benchmark, with a decline of 23.52% compared to the Sensex's gain of 5.27%. This consistent underperformance against the broader market, combined with its high debt and negative EBITDA, suggests that investor sentiment remains cautious, leading to the stock's downward movement.